Fil LTD Iovance Biotherapeutics, Inc. Transaction History

Fil LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$28.04 - $50.26 $4,318 - $7,740	-154 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$19.54 - $38.85 $1,348 - $2,680	-69 Reduced 30.94%	154 $5,000
Q4 2019 Feb 07, 2020	BUY	$17.95 - $29.41 $4,002 - $6,558	223 New	223 $6,000
Q4 2018 Feb 13, 2019	SELL	$7.51 - $11.93 $10 Million - $15.9 Million	-1,336,179 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$11.25 - $17.7 $15 Million - $23.7 Million	1,336,179 New	1,336,179 $15 Million

319

238M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.